Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 15,501–15,525 of 27,380 studies, newest first · page 621 of 1096.

January 2017 25

  1. 2017-01-01

    Cognitive Training Interventions for Patients with Alzheimer's Disease: A Systematic Review

    ✓ Peer-reviewed Prevention trials Journal of Alzheimer's disease : JAD

    Key finding: Despite some positive findings, the inaccurate definitions of CT, inadequate sample sizes, unclear randomization methods, incomplete datasets at follow-up and multiple testing may have inflated the results in many trials. +1 more finding

  2. 2017-01-01

    Multimodal Cognitive Enhancement Therapy for Patients with Mild Cognitive Impairment and Mild Dementia: A Multi- Center, Randomized, Controlled, Double-Blind, Crossover Trial

    ✓ Peer-reviewed Prevention trials Journal of Alzheimer's disease : JAD

    Key finding: Mini-Mental State Examination (effect size = 0.47, p = 0.013) and Alzheimer's Disease Assessment Scale-Cognitive Subscale (effect size = 0.35, p = 0.045) scores were significantly improved in the MCET compared with mock-therapy group. +1 more finding

  3. 2017-01-01

    Tailored and Adaptive Computerized Cognitive Training in Older Adults at Risk for Dementia: A Randomized Controlled Trial

    ✓ Peer-reviewed Prevention trials Journal of Alzheimer's disease : JAD

    Key finding: Home-based CCT with adaptive difficulty and personal tailoring appears superior to more generic CCT in relation to both cognitive and non-cognitive outcomes.

  4. 2017-01-01

    Novel Blood-Based Biomarkers of Cognition, Stress, and Physical or Cognitive Training in Older Adults at Risk of Dementia: Preliminary Evidence for a Role of BDNF, Irisin, and the Kynurenine Pathway

    ✓ Peer-reviewed Prevention trials Journal of Alzheimer's disease : JAD

    Key finding: Stressful life events were associated with reduced BDNF and increased 3-HK. 3-HK decreased after cognitive training, while BDNF tended to increase after physical training. +1 more finding

  5. 2017-01-01

    Synaptic Plasticity, Dementia and Alzheimer Disease

    ✓ Peer-reviewed Disease mechanisms CNS & neurological disorders drug targets

    Key finding: We will consider also emerging data dealing with potential therapeutic approaches for ameliorating the cognitive and memory deficits associated with these disorders.

  6. 2017-01-01

    Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies

    ✓ Peer-reviewed Disease mechanisms Annals of neurology

    Key finding: AV-1451 may have limited utility for in vivo selective and reliable detection of tau aggregates in these non-Alzheimer tauopathies. +2 more findings

  7. 2017-01-01

    Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases

    ✓ Peer-reviewed Inflammation and the immune system Journal of Alzheimer's disease : JAD

    Key finding: However, evidence suggests that smaller soluble aggregates, called oligomers, are the most toxic species and form prior to tangles. +4 more findings

  8. 2017-01-01

    Neurotoxic reactive astrocytes are induced by activated microglia

    ✓ Peer-reviewed Inflammation and the immune system Nature

    Key finding: A subtype of reactive astrocytes, which we termed A1, is induced by classically activated neuroinflammatory microglia. +3 more findings

  9. 2017-01-01

    Qualitative Assessment of Verbal Fluency Performance in Frontotemporal Dementia

    ✓ Peer-reviewed Cognitive tests and assessment Dementia and Geriatric Cognitive Disorders

    Key finding: Interrater reliability was high (median 0.98). +4 more findings

  10. 2017-01-01

    The Determinants of Quality of Life of Nursing Home Residents with Young-Onset Dementia and the Differences between Dementia Subtypes

    ✓ Peer-reviewed Caregiving Dementia and Geriatric Cognitive Disorders

    Key finding: Residents' QoL was negatively associated with advanced dementia, PDU, and NPS. +4 more findings

  11. 2017 no date recorded — placed by publication year

    Alzheimer Europe Publication Highlights Inequalities in Access to Dementia Care and Treatment Across Europe

    ✓ Peer-reviewed Risk factors European Neurological Review

    Key finding: The objective of a new report, ‘European Dementia Monitor 2017: comparing and benchmarking national dementia strategies and policies’, is to provide a benchmark of national dementia policies in order to compare the responses of European countries to the dementia challenge in different domains. +2 more findings

  12. 2017-01-01

    Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate

    ✓ Peer-reviewed Inflammation and the immune system The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: Nevertheless, there has been controversy about what types of oligomers actually confer these AD-like phenotypes. +3 more findings

  13. 2017-01-01

    Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis

    ✓ Peer-reviewed Brain tissue and pathology Journal of Alzheimer's disease : JAD

    Key finding: Cohort studies have reported that midlife high total serum cholesterol (TC) is associated with increased risk of Alzheimer's disease (AD) in late-life but findings have been based on few studies and previous reviews have been limited by a lack of compatible data. +3 more findings

  14. 2017-01-01
  15. 2017-01-01

    Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study

    ✓ Peer-reviewed Long-term cohort studies Journal of Alzheimer's disease : JAD

    Key finding: Plasma amyloid-β (Aβ) levels are increasingly studied as a potential, accessible marker of cognitive impairment and dementia. +3 more findings

  16. 2017-01-01

    Vitamin D and the Risk of Dementia: The Rotterdam Study

    ✓ Peer-reviewed Long-term cohort studies Journal of Alzheimer's disease : JAD

    Key finding: Vitamin D has gained interest as a potentially modifiable risk factor for dementia because of its putative neuroprotective effects. +3 more findings

  17. 2017-01-01
  18. 2017-01-01

    Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer's Disease Pathology in Women versus Men?

    ✓ Peer-reviewed Long-term cohort studies Journal of Alzheimer's disease : JAD

    Key finding: Females show an advantage over males on tests of verbal memory, which are used to diagnose AD and its precursor, amnestic mild cognitive impairment (aMCI). +3 more findings

  19. 2017-01-01

    Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease

    ✓ Peer-reviewed Cognitive tests and assessment Journal of Alzheimer's disease : JAD

    Key finding: Alzheimer's disease (AD) and frontotemporal dementia (FTD) are leading causes of cognitive decline. +3 more findings

  20. 2017-01-01

    The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort

    ✓ Peer-reviewed Cognitive tests and assessment Journal of Alzheimer's disease : JAD

    Key finding: The Montreal Cognitive Assessment (MoCA) has a high sensitivity for detecting cognitive dysfunction. +3 more findings

  21. 2017-01-01

    Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea

    ✓ Peer-reviewed Tau biomarkers Alzheimer disease and associated disorders

    Key finding: Our objective was to apply well-known CSF biomarkers and redetermine their diagnostic cutoff values for AD in South Korea. +3 more findings

  22. 2017-01-01

    Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model

    ✓ Peer-reviewed TREM2 and immune genetics Journal of Alzheimer's disease : JAD

    Key finding: Recently, a rare mutation in the gene Triggering receptor expressed on myeloid cells 2 (TREM2) has been associated with a substantial increase in the risk of developing late onset AD. +3 more findings

  23. 2017-01-01

    Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease

    ✓ Peer-reviewed TREM2 and immune genetics The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: Understanding TREM2 function promises to provide important insights into how neuroinflammation contributes to AD pathology. +3 more findings

  24. 2017-01-01

    AutoDock and AutoDockTools for Protein-Ligand Docking: Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) as a Case Study

    ✓ Peer-reviewed Risk genes beyond APOE Methods in molecular biology (Clifton, N.J.)

    Key finding: Docking is used for optimizing known drugs and for identifying novel binders by predicting their binding mode and affinity. +3 more findings

  25. 2017-01-01

    Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks

    ✓ Peer-reviewed Risk genes beyond APOE Current Alzheimer research

    Key finding: Alzheimer's disease (AD) is the most common neurodegenerative disorder, neuropathologically characterized by aggregates of β-amyloid peptides, which deposit as senile plaques, and of TAU protein, which forms neurofibrillary tangles. +3 more findings

Browse the library by subject, with the full score breakdown →